A biomarker for detecting implant related infection and a method of detecting a biomarker in a sample, said biomarker including at least part of the cnt operon and/or staphylopine. The method is suitable for diagnosing infection of a prosthetic joint and said method including the step of detecting the presence of at least part of the cnt operon and/or staphylopine in said sample.
C12Q 1/689 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour la détection ou l’identification d’organismes pour les bactéries
2.
METHODS AND COMPOSITIONS FOR DRUG RESISTANCE SCREENING
The disclosure relates to novel primers, and their use to detect the presence of drug resistance mutations in a sample from a subject with suspected or confirmed Tuberculosis.
C12Q 1/689 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour la détection ou l’identification d’organismes pour les bactéries
C12Q 1/686 - Réaction en chaine par polymérase [PCR]
A method of identifying and/or isolating one or more bacteriophages that display lytic activity against at least one target bacterial genus, species, or strain. The method includes the creation of a transposon mutant library using at least one bacterial strain from said genus or species and identifying the genes involved in resistance and/or susceptibility by exposing said library to at least one or more bacteriophages.
A method of characterising, modelling and/or profiling a microbiome composition. The method comprises the steps of subjecting metagenomic data from a plurality of microbiomes to at least one multivariate analysis of the relative abundances of bacterial genera in the metagenomic data, thereby identifying recurrent signatures. The signatures represent guilds of co-occurring bacterial genera (enterosignatures).
G16B 20/00 - TIC spécialement adaptées à la génomique ou protéomique fonctionnelle, p. ex. corrélations génotype-phénotype
C12Q 1/689 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour la détection ou l’identification d’organismes pour les bactéries
G16B 40/00 - TIC spécialement adaptées aux biostatistiquesTIC spécialement adaptées à l’apprentissage automatique ou à l’exploration de données liées à la bio-informatique, p. ex. extraction de connaissances ou détection de motifs
5.
GUT BACTERIA DERIVED MICROVESICLES FOR VACCINE DELIVERY
The present invention relates to a vaccine suitable for immunisation against influenza, plague or Y. pestis infection said vaccine comprising outer membrane vesicles (OMVs) and the plague vaccine including the V and/or F1 antigens of Y. pestis.
IMPERIAL COLLEGE INNOVATIONS LIMITED (Royaume‑Uni)
Inventeur(s)
Domoney, Claire
Rayner, Tracey Jane
Frost, Gary
Wilde, Pete
Petropoulou, Aikaterini
Edwards, Cathrina Hansen
Abrégé
The invention relates to methods for determining if a pea variety or a product derived from that pea variety has improved digestion properties. The invention also relates to methods of improving the digestion property of a pea, as well as method of making such plants.
C12N 15/82 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour cellules végétales
A23L 33/21 - Adjonction de substances essentiellement non digestibles, p. ex. de fibres diététiques
C12N 15/52 - Gènes codant pour des enzymes ou des proenzymes
C12Q 1/6895 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour la détection ou l’identification d’organismes pour les plantes, les champignons ou les algues
A composition for labelling, detection, immobilisation and/or isolation of at least one target molecule. The composition including a non-covalent affinity, coupling or binding between vitamin B12 binding protein BtuG2 and at least one bond formed between the vitamin B12 and the target molecule. The interaction between BtuG2 and vitamin B12 enables the labelling, immobilisation, isolation and/or detection of the target molecule.
G01N 33/532 - Production de composés immunochimiques marqués
G01N 33/82 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des vitamines
8.
SATIETY PROMOTING COMPOSITIONS, FOODSTUFFS AND METHODS OF PRODUCTION THEREOF
A dietary composition and methods of producing the same wherein the fibre structure of said composition influences enteroendocrine-mediated appetite regulation. Characterised in that said composition includes intact cells from at least one legume.
A dietary composition and methods of producing the same wherein the fibre structure of said composition influences enteroendocrine-mediated appetite regulation. Characterised in that said composition includes intact cells from at least one legume.
Methods and compositions for substantially preventing or inhibiting tumour growth and/or angiogenesis, said method including the step of co-targeting neuropilin-1 (NRP1) and neuropilin-2 (NRP2) in endothelial cells.
A method of isolating and/or identifying one or more strains of bacteria in a sample, said method comprising the steps of: extracting DNA from the sample, preparing a sequencing library using a long-read sequencing technique, de novo assembly of reads into one or more sequence contigs or assemblies, analysis of sequence contigs or assemblies to identify one or more conserved and/or typing gene operon sequences, analysis of sequence contigs or assemblies to identify PCR primer sites upstream of the one or more conserved and/or typing gene operon sequences, taxonomic classification of upstream PCR primer sites, and/or taxonomic classification of conserved and/or typing gene operon sequences.
C12Q 1/689 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour la détection ou l’identification d’organismes pour les bactéries
G16B 30/00 - TIC spécialement adaptées à l’analyse de séquences impliquant des nucléotides ou des aminoacides
12.
METHOD AND COMPOSITIONS FOR DRUG RESISTANCE SCREENING
The disclosure relates to novel primers, and their use to detect the presence of drug resistance mutations in a sample from a subject with suspected or confirmed Tuberculosis.
C12Q 1/689 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour la détection ou l’identification d’organismes pour les bactéries
13.
DETERMINATION AND QUANTIFICATION OF THE MICROBIAL COMMUNITIES AND ANTIMICROBIAL RESISTANCE GENES ON FOOD
A method of determining and/or quantifying the microorganism communities and genes present on food, said method including the steps of; mixing a sample of said at least one foodstuff with a protease, introducing a triterpene glycoside or saponin to the mixture, introducing a DNase to the mixture, identifying and/or quantifying microorganisms and/or genes by DNA sequencing at least part of the mixture and subjecting the same to metagenomic analysis.
C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
C12Q 1/04 - Détermination de la présence ou du type de micro-organismeEmploi de milieux sélectifs pour tester des antibiotiques ou des bactéricidesCompositions à cet effet contenant un indicateur chimique
C12Q 1/6806 - Préparation d’acides nucléiques pour analyse, p. ex. pour test de réaction en chaîne par polymérase [PCR]
14.
METHODS AND COMPOSITIONS FOR DRUG RESISTANCE SCREENING
The disclosure relates to novel primers, and their use to detect the presence of drug resistance mutations in a sample from a subject with suspected or confirmed Tuberculosis.
C12Q 1/689 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour la détection ou l’identification d’organismes pour les bactéries
15.
BIFIDOBACTERIUM AND COMPOSITIONS THEREOF FOR BREAST CANCER TREATMENT
A composition for the prevention or treatment of breast cancer, said composition including any one or any combination of the bacteria from the genus Bifidobacterium.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
29 - Viande, produits laitiers et aliments préparés ou conservés
30 - Aliments de base, thé, café, pâtisseries et confiseries
Produits et services
Pharmaceuticals, medical and veterinary preparations;
sanitary preparations for medical purposes; dietetic food
and substances adapted for medical or veterinary use, food
for babies; dietary supplements for humans and animals;
plasters, materials for dressings; material for stopping
teeth, dental wax; disinfectants; preparations for
destroying vermin; fungicides, herbicide; food for
diabetics; food for babies; food for diabetics; food for
infants; food for medically restricted diets; food
supplements; food supplements consisting of amino acids;
food supplements consisting of trace elements; food
supplements for dietetic use; food supplements for medical
purposes; food supplements for non-medical purposes; food
supplements for sportsmen; food supplements for veterinary
use; food supplements in liquid form; all the aforementioned
excluding fish oil and derivatives thereof. Meat, fish, poultry and game; meat extracts; preserved,
frozen, dried and cooked fruits and vegetables; jellies,
jams, compotes; eggs; milk and milk products; edible oils
and fats; food pastes made from meat; food pastes made from
meat; food preparations predominantly of milk; food products
made from fish. Coffee, tea, cocoa and coffee substitutes; rice; tapioca and
sago; flour and preparations made from cereals; bread,
pastries and confectionery; edible ices; sugar, honey,
treacle; yeast, baking-powder; salt; mustard; vinegar,
sauces (condiments); spices; ice; foodstuffs made from
cereals; food condiment consisting primarily of ketchup and
salsa; food dressings [sauces]; food flavorings
[non-essential oils]; food flavorings, other than essential
oils; food flavourings; food flavourings [other than
essential oils]; food flavourings, other than essential
oils; food leavening agents; food mixtures consisting of
cereal flakes and dried fruits; food preparations based on
grains; food seasonings.
17.
MEDIUM FOR PRODUCTION OF BACTERIAL EXTRACELLULAR VESICLES
A method of transposon insertion sequencing (TIS) capable of resolving insertion sites in or around repeat elements, said method including the steps of; preparing a pool or library of mutant cells by introduction or insertion of one or more transposon sequences, extraction of DNA from said cells, DNA fragmentation, DNA amplification, and characterised in that the amplified DNA is sequenced by a long-read sequencing method.
A method of potentiating or inducing antibiotic efficacy in one or more compositions or compounds, said method including the step of inducing a substantially cell wall deficient (CWD) state in a bacteria by exposure to at least one antibiotic before and/or in combination with said one or more compositions or compounds.
A61K 31/395 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines
A61K 31/407 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à cinq chaînons avec un azote comme seul hétéro-atome d'un cycle, p. ex. sulpiride, succinimide, tolmétine, buflomédil condensés avec des systèmes hétérocycliques, p. ex. kétorolac, physostigmine
A61K 31/43 - Composés contenant des systèmes cycliques thia-4 aza-1 bicyclo [3.2.0] heptane, c.-à-d. composés contenant un système cyclique de formule , p. ex. pénicillines, pénèmes
A61K 31/4745 - QuinoléinesIsoquinoléines condensées en ortho ou en péri avec des systèmes hétérocycliques condensées avec des systèmes cycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. phénanthrolines
A61K 31/496 - Pipérazines non condensées contenant d'autres hétérocycles, p. ex. rifampine, thiothixène ou sparfloxacine
A61K 31/665 - Composés du phosphore ayant l'oxygène comme hétéro-atome d'un cycle, p. ex. fosfomycine
A61K 31/7036 - Composés ayant des radicaux saccharide liés à des composés non-saccharide par des liaisons glycosidiques liés à un composé carbocyclique, p. ex. phloridzine ayant au moins un groupe amino lié directement au carbocycle, p. ex. streptomycine, gentamycine, amikacine, validamycine, fortimicines
A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p. ex. composés antiphlogistiques et pour le cœur
Pharmaceutical compositions and preparation including outer membrane vesicles (OMVs) and at least one pharmaceutically acceptable carrier wherein said OMVs are native OMVs produced by the Gram-negative commensal bacteria Bacteroides.
A61K 39/39 - Préparations médicinales contenant des antigènes ou des anticorps caractérisées par les additifs immunostimulants, p. ex. par les adjuvants chimiques
21.
PRODUCTION AND MODIFICATION OF BACTERIAL MICROCOMPARTMENTS AND USE THEREOF
C07K 14/24 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant de bactéries provenant d'Entérobacteriaceae (F), p. ex. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
G01N 33/532 - Production de composés immunochimiques marqués
G01N 33/58 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des substances marquées
G01N 33/82 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des vitamines
23.
COMPOSITIONS AND METHODS FOR EXTRACELLULAR VESICLE DRUG DELIVERY
A method of producing a vaccine, said method including the steps of; isolating at least one microbial and/or viral protein or antigen, bonding the microbial and/or viral protein or antigen to vitamin B12 (vitB12) and wherein the vitB12 attached proteins or antigens are mixed with outer membrane vesicles (OMVs).
A method of identifying genes, or proteins encoded by said genes, in a microbe that contribute or influence antimicrobial sensitivity, including the steps of; producing a transposon mutant library with sequencing of all transposon–chromosome insertion junction sites in parallel, identifying primary target genes or gene products within the mutant library that contribute to microbe sensitivity to a first antimicrobial compound by subjecting said mutants to growth or survival under a number of test conditions, and wherein secondary target genes or gene products are identified from the library or primary target genes or gene products, that are sensitive to at least one second compound.
IMPERIAL COLLEGE INNOVATIONS LIMITED (Royaume‑Uni)
Inventeur(s)
Domoney, Claire
Rayner, Tracey Jane
Frost, Gary
Wilde, Pete
Petropoulou, Aikaterini
Edwards, Cathrina Hansen
Abrégé
The invention relates to methods for determining if a pea variety or a product derived from that pea variety has improved digestion properties. The invention also relates to methods of improving the digestion property of a pea, as well as method of making such plants.
The disclosure relates to novel primers, and their use to detect the presence of drug resistance mutations in a sample from a subject with suspected or confirmed Tuberculosis.
C12Q 1/689 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour la détection ou l’identification d’organismes pour les bactéries
28.
Engineering gut commensal bacteria to express heterologous proteins in their outer membrane vesicles (OMVS) for delivery to the GI-tract
This invention relates to the delivery of heterologous peptides or proteins such as therapeutic peptides, therapeutic proteins or antigens to mucosal sites using vesicles derived from the outer membrane of commensal bacteria, recombinant bacteria capable of producing such vesicles, and methods for the production of such vesicles. The invention further relates to an inducible expression system for use in recombinant bacteria.
A61K 39/39 - Préparations médicinales contenant des antigènes ou des anticorps caractérisées par les additifs immunostimulants, p. ex. par les adjuvants chimiques
A method of identifying, monitoring and/or diagnosing mucosal bacterial presence or infection, said method including the step of detecting at least part of a sialic acid transporter protein encoded by Ruminococcus gnavus (R. gnavus) ATCC 29149 Nan cluster. In addition, a method of inhibition of the growth of bacterium, said method including the step of inhibition of a sialic acid transporter protein is included.
C12Q 1/689 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour la détection ou l’identification d’organismes pour les bactéries
C12Q 1/04 - Détermination de la présence ou du type de micro-organismeEmploi de milieux sélectifs pour tester des antibiotiques ou des bactéricidesCompositions à cet effet contenant un indicateur chimique
C12Q 1/686 - Réaction en chaine par polymérase [PCR]
A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p. ex. composés antiphlogistiques et pour le cœur
30.
Delivery of Bacteria-Derived Outer Membrane Vesicles
A61K 39/39 - Préparations médicinales contenant des antigènes ou des anticorps caractérisées par les additifs immunostimulants, p. ex. par les adjuvants chimiques
A method of identifying contribution of a genomic variation to a phenotypic feature is disclosed. The method comprises determining a degree of a genomic variation (51; Fig. ) in each individual in a set of individuals and recording the degree of genomic variation in each individual in a database, for example, in a first table (6). The method comprises determining a location of the genomic variation to allow determination, by virtue of the location, of whether the genomic variation affects a gene product directly and/or regulates production of a gene product (53, 54; Fig. 5). The method comprises determining a first gene (51; Fig. 5) affected by the genomic variation. When the genomic variation affects a gene product directly, recording the gene, in the coding sequence of which the genomic variation is located, as the first gene, for example, in a second table (7). When the genomic variation regulates the production of a gene product, recording the gene, in the promoter region or other regulatory region of which the genomic variation is located, as the first gene. The method comprises determining an outcome of the genomic variation on the first gene and recording the outcome of the genomic variation in the database, for example, in the second table and determining the presence or absence of one or more other gene products (i) interacting with the first gene, (ii) encoded by the first gene; and/or (iii) regulating the first gene and, if present, recording the identity of the gene encoding the one or more other gene products in the database as the second gene, for example, in the second table.
G16B 5/00 - TIC spécialement adaptées à la modélisation ou aux simulations dans la biologie des systèmes, p. ex. réseaux de régulation génétique, réseaux d’interaction entre protéines ou réseaux métaboliques
G16B 20/20 - Détection d’allèles ou de variantes, p. ex. détection de polymorphisme d’un seul nucléotide
32.
GUT BACTERIA DERIVED MICROVESICLES FOR VACCINE DELIVERY
The present invention relates to a vaccine suitable for immunisation against influenza, plague or Y. pestis infection said vaccine comprising outer membrane vesicles (OMVs) and the plague vaccine including the V and/or F1 antigens of Y. pestis.
uminococcus gnavusgnavusgnavus) ATCC 29149 Nan cluster. In addition, a method of inhibition of the growth of bacterium, said method including the step of inhibition of a sialic acid transporter protein is included.
C12Q 1/04 - Détermination de la présence ou du type de micro-organismeEmploi de milieux sélectifs pour tester des antibiotiques ou des bactéricidesCompositions à cet effet contenant un indicateur chimique
C12Q 1/689 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour la détection ou l’identification d’organismes pour les bactéries
A61K 38/00 - Préparations médicinales contenant des peptides
34.
Engineering gut commensal bacteria to express heterologous proteins in their outer membrane vesicles (OMVs) for delivery to the GI-tract
This invention relates to the delivery of heterologous peptides or proteins such as therapeutic peptides, therapeutic proteins or antigens to mucosal sites using vesicles derived from the outer membrane of commensal bacteria, recombinant bacteria capable of producing such vesicles, and methods for the production of such vesicles. The invention further relates to an inducible expression system for use in recombinant bacteria.
A01N 63/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des micro-organismes, des virus, des champignons microscopiques, des animaux ou des substances produites par, ou obtenues à partir de micro-organismes, de virus, de champignons microscopiques ou d'animaux, p. ex. enzymes ou produits de fermentation
The present invention relates to an intramolecular trans-sialidase (IT-sialidase) enzyme from Ruminococcus gnavus and fragments thereof. It also relates to methods of production of the IT-sialidase or its fragments, in addition to uses of the IT-sialidase, its fragments, or compositions comprising the IT-sialidase. One of the uses of the IT-sialidase or its fragments encompassed by the present invention is a method for production of 2,7-anhydro sialic acid derivatives. Further uses of the IT-sialidase enzyme include the therapeutic and prophylactic treatment of infections and respiratory conditions.
C12N 9/26 - Hydrolases (3.) agissant sur les composés glycosyliques (3.2) agissant sur les liaisons alpha-glucosidiques-1, 4, p. ex. hyaluronidase, invertase, amylase
This invention relates to the delivery of heterologous peptides or proteins such as therapeutic peptides, therapeutic proteins or antigens to mucosal sites using vesicles derived from the outer membrane of commensal bacteria, recombinant bacteria capable of producing such vesicles, and methods for the production of such vesicles. The invention further relates to an inducible expression system for use in recombinant bacteria.
This invention relates to the delivery of heterologous peptides or proteins such as therapeutic peptides, therapeutic proteins or antigens to mucosal sites using vesicles derived from the outer membrane of commensal bacteria, recombinant bacteria capable of producing such vesicles, and methods for the production of such vesicles. The invention further relates to an inducible expression system for use in recombinant bacteria.
The present invention relates to S-methylcysteine sulfoxide and compositions thereof for use in the treatment or prevention of prostate cancer. It also relates to analogues, derivatives or metabolites of S-methylcysteine sulfoxide for use in the treatment or prevention of prostate cancer. Compositions of S-methylcysteine sulfoxide or its analogues, derivatives or metabolites may be provided for oral consumption, for example as a pharmaceutical composition, a medicament or a food composition.
A method for detecting a marker in a sample is provided. The method comprises adding solvent to the coffee to prepare a sample; scanning the sample using low-field NMR spectroscopy to generate a spectral fingerprint, and; analysing the spectral fingerprint, wherein the presence of a fingerprint unique to the marker indicates the presence of the marker, wherein the marker is caffeine or 16-OMC.
G01N 24/08 - Recherche ou analyse des matériaux par l'utilisation de la résonance magnétique nucléaire, de la résonance paramagnétique électronique ou d'autres effets de spin en utilisant la résonance magnétique nucléaire
The present invention relates to an intramolecular frans-sialidase (IT-sialidase) enzyme from Ruminococcus gnavus and fragments thereof. It also relates to methods of production of the IT- sialidase or its fragments, in addition to uses of the IT-sialidase, its fragments, or compositions comprising the IT-sialidase. One of the uses of the IT-sialidase or its fragments encompassed by the present invention is a method for production of 2,7-anhydro sialic acid derivatives. Further uses of the IT-sialidase enzyme include the therapeutic and prophylactic treatment of infections and respiratory conditions.
A61K 31/7012 - Composés ayant un groupe carboxyle libre ou estérifié, lié directement ou par une chaîne carbonée, à un atome de carbone du radical saccharide, p. ex. acide glucuronique, acide neuraminique
A61K 47/26 - Hydrates de carbone, p. ex. polyols ou sucres alcoolisés, sucres aminés, acides nucléiques, mono-, di- ou oligosaccharidesLeurs dérivés, p. ex. polysorbates, esters d’acide gras de sorbitan ou glycyrrhizine
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
05 - Produits pharmaceutiques, vétérinaires et hygièniques
09 - Appareils et instruments scientifiques et électriques
10 - Appareils et instruments médicaux
16 - Papier, carton et produits en ces matières
29 - Viande, produits laitiers et aliments préparés ou conservés
30 - Aliments de base, thé, café, pâtisseries et confiseries
31 - Produits agricoles; animaux vivants
32 - Bières; boissons non alcoolisées
33 - Boissons alcoolisées à l'exception des bières
40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
41 - Éducation, divertissements, activités sportives et culturelles
42 - Services scientifiques, technologiques et industriels, recherche et conception
43 - Services de restauration (alimentation); hébergement temporaire
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.
Produits et services
(1) Chemical, biochemical and biological, reagents and preparations, other than for medical and veterinary purposes, namely, bacterial cultures for addition to food and beverage products, and bacterial cultures for use in food and beverage manufacturing; chemical, biochemical and biological, reagents and preparations, other than for medical and veterinary purposes, namely, chemical and biochemical additives for use in the manufacture of food and beverages; chemical, biochemical and biological substances, reagents and preparations used in tests and for testing other than for medical or for veterinary purposes, namely, diagnostic reagents for scientific research use that test for contaminants in food and beverages; chemical, biochemical or biological substances, reagents or preparations for in vitro or in vivo tests, other than for medical and veterinary purposes, namely, diagnostic reagents for in vitro use in biochemistry and microbiology; biological reaction testing devices, namely, laboratory assay kits
(2) Chemical, biochemical and biological reagents and preparations for medical and for veterinary purposes, namely, reagents and biochemical preparations that originate in, and are transported through the gut for the detection and treatment of viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynaecological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders namely diagnostic biomarker reagents, diagnostic reagents, and in vitro and in vivo diagnostic preparations for medical and veterinary purposes; chemical and biochemical preparations for diagnostic use for medical and veterinary purposes, namely, biochemical preparations that originate in, and are transported through the gut for the diagnosis of viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynaecological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders by absorption and transport of said preparations through the gut namely diagnostic biomarker reagents, diagnostic reagents, and in vitro and in vivo diagnostic preparations for medical and veterinary purposes; diagnostic agents of biological origin in the human and animal gut for use in medical and veterinary diagnosis, namely, diagnostic biomarker reagents for medical and veterinary purposes; chemical, biochemical and biological substances, reagents and preparations used in test and for testing for medical and for veterinary purposes, namely, diagnostic reagents for medical use and diagnostic reagents for veterinary use; chemical , biochemical or biological substances, reagents or preparations that originate in, and are transported through the gut for in vitro or in vivo tests for medical and for veterinary purposes, namely, in vitro and in vivo diagnostic preparations for medical and veterinary purposes; dietetic food and substances adapted for medical or veterinary use, namely, food for babies; dietary supplements for humans, namely, dietary supplements for general health and well-being; dietary supplements for and animals, namely, vitamin and mineral dietary supplements for animals; vitamin and mineral food supplements; health supplements, namely, nutritional supplements for general health and well-being; vitamins, minerals and other nutraceuticals, namely, vitamin and mineral dietary supplements; pre-biotics, namely, prebiotic preparations for medical purposes to help maintain a natural balance of flora in the digestive system; pro-biotics, namely, probiotic preparations for medical purposes to help maintain a natural balance of flora in the digestive system; microorganisms for use in food and beverages, namely, prebiotic preparations and probiotic preparations for use in food and beverages for medical purposes to help maintain a natural balance of flora in the digestive system; fungicides; herbicides
(3) Computers and computer programs for chemical, biochemical and biological analysis of data in the field of microbiology and food science; software for the collection and storage of analytical data in the fields of bacteriological analysis, biochemical analysis, chemical analysis, and food science; diagnostic testing equipment, namely, incubators for bacteria cultures, laboratory test tubes, pipettes, chromatography columns for laboratory use, and laboratory centrifuges; forensic testing equipment, namely, mass spectrometers, biological microscopes, and chromatography apparatus for laboratory use; hygiene testing equipment, namely, test strips impregnated with reagents for testing the sterility of medical, surgical and veterinary equipment; food testing equipment, namely, laboratory thermometers, digital pH meters, refractometers, mass spectrometers, spectrophotometers, and laboratory instruments for the detection of pathogens and toxins in food samples for research use; instruments and measuring apparatus for physical testing, namely, medical scales; biological and microbiological testing equipment, namely, petri dishes, drying ovens for laboratory use, and electrophoresis units; downloadable electronic publications in the fields of health, hygiene, nutrition, diet and food;
(4) Surgical instruments for monitoring chemical, biochemical and biological reaction and systems; veterinary instruments for monitoring chemical, biochemical and biological reaction and systems; surgical instruments for the preparation, screening and analysis of samples and specimens; veterinary instruments for the preparation, screening and analysis of samples and specimens; surgical genetic testing equipment, namely, thermal cyclers for use in genetic testing for surgical purposes; medical genetic testing equipment, namely, thermal cyclers for use in genetic testing for medical purposes; veterinary genetic testing equipment, namely, thermal cyclers for use in genetic testing for veterinary purposes; forensic testing equipment for medical purposes, namely, gas chromatography apparatus for forensic medical purposes, thermal cyclers for use in genetic testing for forensic medical purposes, thermometers for forensic medical purposes, and mass spectrometers for forensic medical purposes; surgical diagnostic testing equipment, namely, magnetic resonance imaging (MRI) diagnostic apparatus for surgical purposes and ultrasonic medical diagnostic apparatus for surgical purposes; medical diagnostic testing equipment, namely, magnetic resonance imaging (MRI) diagnostic apparatus for medical purposes and ultrasonic medical diagnostic apparatus for medical purposes; veterinary diagnostic testing equipment, namely, magnetic resonance imaging (MRI) diagnostic apparatus for veterinary purposes and ultrasonic medical diagnostic apparatus for veterinary purposes
(5) Printed matter, namely, brochures, flyers, and magazines; printed publications, namely, medical publications and printed publications in the fields of microbiology, gastrointestinal health, diet and nutrition;
(6) Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits and vegetables; jellies, jams, compotes; eggs; milk and milk products; edible oils and fats; food products made from the aforesaid ingredients, namely, yogurt and dairy beverages;
(7) Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations made from cereals, namely, rolled oats and wheat, oat flakes, barley meal, and wheat germ; bread, pastries and confectionery, namely, sugar confectionery, chocolate confectionery, almond confectionery and peanut confectionery; edible ices; sugar, honey, treacle; yeast, yeast cultures; baking powder; salt; mustard, vinegar, sauces, namely, ketchup, mayonnaise, relishes, hot sauce, and chutney condiments; spices; ices; food products made from the aforesaid ingredients, namely, dough and breakfast cereals;
(8) Agricultural, horticultural and forestry products, namely, bulbs, spores, spawn and seeds for agricultural purposes, and bulbs and seeds horticultural purposes; fresh fruits and vegetables; natural plants and flowers; foodstuffs for animals, namely, animal feed; malt for brewing and distilling; raw and unprocessed grains and unprocessed seeds for agricultural purposes
(9) Beers; mineral and aerated waters and other non-alcoholic beverages, namely, soft drinks; fruit beverages and fruit juices; syrups for making beverages; powders and concentrates used in the preparation of fruit-based drinks, soft drinks and effervescing beverages;
(10) Alcoholic beverages (except beers), namely, wine, brandy, gin, rum, tequila, vodka, whisky, and liqueurs; (1) Treatment of waste water; treatment of industrial waste and food waste; advisory, information and consultancy services in the fields of the treatment of waste water, industrial waste and food waste;
(2) Instruction services, namely, instruction in the fields of health, hygiene, nutrition, diet and food; educational services in the fields of health, hygiene, nutrition, diet and food; educational services in the fields of food technology; information exchange services between scientists, researchers, commercial and industrial entities namely educational, teaching and training services; providing conference facilities; providing on-line electronic publications, not downloadable, in the fields of health, hygiene, nutrition, diet and food; publication of electronic books and journals on-line; publication of texts, other than publicity texts; teaching nutrition; writing of electronic books, magazines, and journals; advisory, information and consultancy services in the fields of providing instruction and educational services in the fields of health, hygiene, nutrition, diet, food, and food technology; advisory, information and consultancy services in the field of information exchange services between scientists, researchers, commercial and industrial entities namely educational, teaching and training services; advisory, information and consultancy services in the field of publication of texts, other than publicity texts and writing of electronic books, magazines, and journals;
(3) Analytic laboratory services, namely, bacteriological analysis, chemical analysis and biochemical analysis; food intolerance, food analysis, food technology, food science and food safety studies; contract research, namely, research for others in the fields of molecular chemistry and molecular biology; computerized food analysis services, namely, chemical, biochemical and bacteriological analysis of food using computer systems; provision of scientific information on food safety testing; quality control in the field of hygiene; research in the fields of health, hygiene, nutrition, diet and food; research into the treatment of waste materials; research into the treatment of biomass; information exchange services between scientists, researchers, commercial and industrial entities namely industrial analysis and research projects, provision of scientific, technological and research information; laboratory research in the fields of chemistry, biochemistry, microbiology, and food science; laboratory testing services, namely, laboratory testing of materials, medical laboratory services and veterinary laboratory services; pharmaceutical research and development services; project studies, namely, conducting scientific feasibility studies; mathematical research services, namely, statistical analysis of data from scientific studies in the fields of chemistry, biochemistry, microbiology, and food science ; preparation of reports relating to technical and scientific research, namely, technical writing of reports in the fields of chemistry, biochemistry, microbiology, and food science; provision of scientific information in the fields of chemistry, biochemistry, microbiology and food science; creating, testing, implementing, developing, maintaining, updating, and providing advisory and consultancy services in the fields of computer programs, computer networks, websites, web pages; advisory, information and consultancy services related to the aforesaid, namely, computer software consulting;
(4) Advisory services in the fields of health, hygiene, nutrition and diet; consultancy and counselling services in the fields of health, hygiene, nutrition and diet; provision of information in the fields of health, hygiene, nutrition and diet; professional consultancy in the fields of health, hygiene, nutrition and diet
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
05 - Produits pharmaceutiques, vétérinaires et hygièniques
09 - Appareils et instruments scientifiques et électriques
10 - Appareils et instruments médicaux
16 - Papier, carton et produits en ces matières
29 - Viande, produits laitiers et aliments préparés ou conservés
30 - Aliments de base, thé, café, pâtisseries et confiseries
31 - Produits agricoles; animaux vivants
32 - Bières; boissons non alcoolisées
33 - Boissons alcoolisées à l'exception des bières
40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
41 - Éducation, divertissements, activités sportives et culturelles
42 - Services scientifiques, technologiques et industriels, recherche et conception
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.
Produits et services
Chemical, biochemical and biological, reagents and preparations, other than for medical or for veterinary purposes, chemical, biochemical and biological substances, reagents and preparations used in tests and for testing other than for medical or for veterinary purposes; chemical, biochemical or biological substances, reagents or preparations for in vitro or in vivo tests (other than for medical or veterinary purposes). Chemical, biochemical and biological reagents and preparations for medical or for veterinary purposes; chemical and biochemical preparations for diagnostic use for medical or veterinary purposes; diagnostic agents of biological origin for use in medical or veterinary diagnosis; chemical, biochemical and biological substances, reagents and preparations used in test and for testing for medical or for veterinary purposes; chemical, biochemical or biological substances, reagents or preparations for in vitro or in vivo tests for medical or for veterinary purposes; dietetic food and substances adapted for medical or veterinary use, food for babies; dietary supplements for humans and animals; food supplements; health supplements; vitamins, minerals and other nutraceuticals; prebiotics, probiotics; microorganisms for use in food and beverages; fungicides; herbicides. Scientific instruments; computers and computer programs; software for use in data capturing and storage; detectors for scientific use; diagnostic testing equipment; forensic testing equipment; hygiene testing equipment; food testing equipment; automated testing apparatus; apparatus and instruments for analysing biological reactions (for laboratory and scientific use); biological reaction testing devices; biological reaction analysers; instruments and measuring apparatus for physical testing, biological and microbiological testing equipment; downloadable publications. Surgical apparatus and instruments for monitoring chemical, biochemical and biological reaction and systems; veterinary apparatus and instruments for monitoring chemical, biochemical and biological reaction and systems; surgical apparatus and instruments for the preparation, screening and analysis of samples and specimens; veterinary apparatus and instruments for the preparation, screening and analysis of samples and specimens; surgical genetic testing equipment; medical genetic testing equipment; veterinary genetic testing equipment; forensic testing equipment for medical purposes; hygiene testing equipment; surgical, diagnostic testing equipment; medical diagnostic testing equipment; veterinary diagnostic testing equipment. Printed matter; printed publications. Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits and vegetables; jellies, jams, compotes; eggs; milk and milk products; edible oils and fats; food products made from the aforesaid ingredients. Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations made from cereals; bread, pastries and confectionery; edible ices; sugar, honey, treacle; yeast, yeast cultures; baking powder; salt; mustard, vinegar, sauces (condiments); spices; ices; food products made the aforesaid ingredients. Agricultural, horticultural and forestry products; fresh fruits and vegetables; natural plants and flowers; foodstuffs for animals; malt; raw and unprocessed grains and seeds. Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages and fruit juices; syrups and other preparations for making beverages. Alcoholic beverages (except beers). Treatment of waste materials; treatment of industrial waste including food waste; advisory, information and consultancy services related to the aforesaid. Instruction services; educational services relating to health, hygiene, nutrition, diet and food; educational services relating to food technology; instruction in diet (non medical); provision of training relating to health, hygiene, diet and food; training services relating to health hygiene, nutrition, diet and food; information exchange services between scientists, researchers, commercial and industrial entities namely educational, teaching and training services; providing conference facilities; providing on-line electronic publications, not downloadable; publication of electronic books and journals on-line; publication of texts, other than publicity texts; teaching; texts (writing of-), other than publicity texts; tuition; advisory, information and consultancy services related to the aforesaid. Scientific and- industrial research and- design services; analytic laboratory services; food intolerance, food analysis, food technology, food science and food safety studies; contract research services relating to molecular sciences; computerized food analysis services; provision of information on food safety; quality control relating to hygiene; research relating to health, hygiene, nutrition, diet and food; research into the treatment of waste materials; research into the treatment of biomass; information exchange services between scientists, researchers, commercial and industrial entities namely industrial analysis and research projects, provision of scientific, technological and research information; laboratory research; laboratory testing services; scientific and technological services and research and design thereto; pharmaceutical research and development services; project studies (technical -); mathematical research services; preparation of reports relating to technical or scientific research; provision of information relating to scientific or technical research; creating, testing, implementing, developing, maintaining, updating, and providing advisory and consultancy services in relation to computer programs, computer networks, websites, web pages and mobile apps; advisory, information and consultancy services related to the aforesaid. Advisory services relating to health, hygiene, nutrition and diet; consultancy and counselling services relating to health, hygiene, nutrition and diet; provision of information relating to health, hygiene, nutrition and diet; professional consultancy relating to health, hygiene, nutrition and diet.
